Sarepta Therapeutics (AB3A) Q2 2024 Earnings Report
CH:AB3A Q2 2024 EPS Results
- Actual EPS
- CHF 0.06
- Consensus EPS
- -CHF 0.11
- Beat/Miss
- Beat by +CHF 0.16
- One Year Ago EPS
- -CHF 0.22
CH:AB3A Q2 2024 Revenue Results
- Actual Revenue
- CHF 299.00M
- Expected Revenue
- CHF 324.91M
- Beat/Miss
- Missed by -CHF 25.91M
- YoY Revenue Growth
- +38.93%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- After Close
- Conference Call
- Wednesday, August 7, 2024
CH:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:AB3A Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.06- | -1.48 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 0.18-0.04 | 1.56 | -102.65% (-1.60) | |
| May 06, 2026 | 2026 (Q1) | 0.802.37 | -3.79 | 162.61% (+6.16) | |
| Feb 25, 2026 | 2025 (Q4) | -0.99-3.24 | 1.24 | -362.00% (-4.47) | |
| Nov 03, 2025 | 2025 (Q3) | -0.60-1.48 | 0.28 | -629.41% (-1.76) | |
| Aug 06, 2025 | 2025 (Q2) | 0.691.56 | 0.06 | 2600.00% (+1.50) | |
| May 06, 2025 | 2025 (Q1) | -2.64-3.79 | 0.3 | -1343.24% (-4.09) | |
| Feb 26, 2025 | 2024 (Q4) | 1.551.24 | 0.39 | 219.15% (+0.85) | |
| Nov 06, 2024 | 2024 (Q3) | -0.060.28 | -0.38 | 173.91% (+0.66) | |
| Aug 07, 2024 | 2024 (Q2) | -0.110.06 | -0.22 | 125.93% (+0.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed